Gwen Melincoff

Track

Insider profile

Currently holds a position at Collegium Pharmaceutical Inc

Performance

Overall performance
3.1
Performance over holding periods
3.1
30 days 90 days 120 days
Average return 11% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
1 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Independent Director Collegium Pharmaceutical Inc Aug. 9, 2017 -
Gwen Melincoff's trades of Collegium Pharmaceutical Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
384.56
Quantity 58,777
Value US$2,594,291
Transaction date
Proposed sale
Price
39.70
Quantity 949
Value US$4,772,270
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-07-02 2025-07-02
PrS Proposed sale
58,777
384.56
US$2,594,291 		58,777 384.56 US$2,594,291
2024-06-28 2024-06-28
PrS Proposed sale
949
39.70
US$4,772,270 		949 39.70 US$4,772,270
2019-11-20 2019-11-19
B Purchase
75,053 +29.0%
106.63
US$1,202,300 		75,053 +29.0% 106.63 US$1,202,300